Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 88.40
-0.60 (-0.67%)
Jun 16, 2026, 1:45 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.49 billion as of June 16, 2026. Its market cap has decreased by -11.86% in one year.
Market Cap
1.49B
Enterprise Value
1.47B
Revenue
257.50M
Ranking
n/a
PE Ratio
99.47
Stock Price
88.40
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.49B, an increase of 10.54%. That is a compound annual growth rate of 2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.49B | -21.44% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.50B |
| C-Rad AB | 1.25B |
| Paxman AB | 1.19B |
| BICO Group AB | 1.15B |
| Sedana Medical AB | 835.42M |
| Senzime AB | 705.90M |
| Bactiguard Holding AB | 553.69M |
| SciBase Holding AB | 499.51M |